USP15 increases TP53 stability and subsequent TP53-mediated cyclin-dependent kinase inhibitor 1A (CDKN1A) gene expression to inhibit proliferation of human osteosarcoma cell line U2OS [48]. Here, CDKN1A is linked to osteosarcoma.